Skip to content

Debt-to-assets at other companies

Baxter International logo
Baxter InternationalBAX
0.0×
PTH
Pelthos Therapeutics Inc.PTHS
0.2×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
0.1×+0.1×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
2.4×+2.4×
RFL
Rafael Holdings, Inc.RFL
0.2×+0.2×
Opko Health logo
Opko HealthOPK
0.0×

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Calculated from Cumberland Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's debt-to-assets?
Cumberland Pharmaceuticals (CPIX) reported debt-to-assets of 0.1× in Q1 2026.
How has Cumberland Pharmaceuticals's debt-to-assets changed year-over-year?
Cumberland Pharmaceuticals's debt-to-assets decreased by 8.6% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for Cumberland Pharmaceuticals's debt-to-assets?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's debt-to-assets has grown at a 24.5% compound annual growth rate (CAGR), from 0× to 0.1×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.